RAER therapeutics
What we do
At RAER Therapeutics, we find innovative therapies for rare diseases, especially genetic disorders. By leveraging a unique, rapid, and cost-effective screening platform to develop novel and repurposed leads, we address significant unmet medical needs in a market with limited effective treatments.
How we work
RAER combines a scalable business model with service contracts, collaborations, and licensing; we address the challenge of patient recruitment through an extensive worldwide patient network.
We have advanced projects in RASopathies, TAUopathies, and Adenoid Cystic Carcinoma using Drosophila and other cutting edge screening techniques.
Contact Us
Want to learn more? Reach out, and we will be in touch shortly.